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In Brief
Scott et al. demonstrate that ZEB2 is
critical for maintaining the tissue
identities of macrophages. Loss of ZEB2
results in tissue-specific changes in
different macrophage populations and
their subsequent disappearance. In
Kupffer cells, ZEB2 maintains LXRa
expression, loss of which reproduces the
change in Kupffer cell identity and their
disappearance..
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Heterogeneity between different macrophage pop-
ulations has become a defining feature of this
lineage. However, the conserved factors defining
macrophages remain largely unknown. The tran-
scription factor ZEB2 is best described for its role
in epithelial to mesenchymal transition; however,
its role within the immune system is only now being
elucidated. We show here that Zeb2 expression is
a conserved feature of macrophages. Using
Clec4f-cre, Itgax-cre, and Fcgr1-cre mice to target
five different macrophage populations, we found
that loss of ZEB2 resulted in macrophage disap-
pearance from the tissues, coupled with their
subsequent replenishment from bone-marrow pre-
cursors in open niches. Mechanistically, we found
that ZEB2 functioned to maintain the tissue-spe-
cific identities of macrophages. In Kupffer cells,
ZEB2 achieved this by regulating expression of
the transcription factor LXRa, removal of which
recapitulated the loss of Kupffer cell identity and
disappearance. Thus, ZEB2 expression is required
in macrophages to preserve their tissue-specific
identities.312 Immunity 49, 312–325, August 21, 2018 ª 2018 The Author(s). P
This is an open access article under the CC BY license (http://creativeINTRODUCTION
Most macrophages (macs) arise during embryogenesis from
either yolk-sac macs or fetal liver monocytes and self-maintain
throughout life in most tissues (Ginhoux and Guilliams, 2016).
In a selection of tissues including the heart, gut, and dermis,
this self-maintenance is partially abrogated resulting in the
continual replenishment of these macs from bone marrow (BM)
monocytes (Ginhoux and Guilliams, 2016). In addition, macs
across different organs are highly heterogeneous (Gautier
et al., 2012; Gosselin et al., 2014; Lavin et al., 2014) and
contribute to tissue homeostasis by performing different ‘‘acces-
sory functions’’ in their specific tissues of residence (Okabe and
Medzhitov, 2016). Research has recently been focused on un-
derstanding the heterogeneity of macs from one tissue to
another, but it remains largely unknown if macs also require
some conserved factors for their identity, irrespective of their tis-
sue of residence. While high expression of the transcription fac-
tor (TF) PU.1 (Monticelli and Natoli, 2017) and dependence on
signaling through the colony stimulating factor-1 receptor
(CSF1R) (Gow et al., 2014; Hume et al., 1988; Tagliani et al.,
2011; Wang et al., 2012) are characteristics of the mac lineage,
not much else is known regarding additional conserved TFs
that drive and maintain these cells.
Zinc finger E box binding homeobox 2 (ZEB2, SIP1, ZFXH1B)
is a TF best known for its role in epithelial to mesenchymal tran-
sition (EMT), in which epithelial cells lose their cellular identityublished by Elsevier Inc.
commons.org/licenses/by/4.0/).
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and are converted into mesenchymal cells (Brabletz and Bra-
bletz, 2010). EMT transitions are crucial in embryonic develop-
ment, wound healing, and cancer (De Craene and Berx, 2013).
Mice lacking Zeb2 are embryonic lethal (Higashi et al., 2002),
while patients with heterozygous abnormalities in Zeb2 often
develop Hirschsprung’s disease and Mowat-Wilson syndrome
(Vandewalle et al., 2009). In the immune system, it has recently
been reported that ZEB2 functions to regulate NK cell maturation
(van Helden et al., 2015), the terminal differentiation of CD8+
effector T cells (Dominguez et al., 2015; Omilusik et al., 2015),
and the differentiation and development of pDCs and cDC2s
(Scott et al., 2016a; Wu et al., 2016). Additionally, ZEB2 has
been suggested to play a role in controlling the fate of the gran-
ulocyte-macrophage progenitor (GMP) (Wu et al., 2016). Here,
we examined Zeb2 expression in a variety of mac populations
and show that high expression of Zeb2 is a conserved feature
of the mac lineage. Furthermore, we found that loss of ZEB2 in
five different macs resulted in the loss of their tissue identities
and their subsequent disappearance. More specifically, we
found that ZEB2 functions to maintain KC identity, at least in
part, by regulating expression of the TF LXRa (Nr1h3).
RESULTS
Zeb2 Expression Is Conserved across the Mac Lineage
Although macs represent a highly heterogeneous lineage (Gaut-
ier et al., 2012; Lavin et al., 2014; Scott et al., 2016b), we sought
here to identify TFs conserved across the mac lineage. To this
end, we compiled data from the Immgen Consortium, our previ-
ously published studies (Scott et al., 2016b; van de Laar et al.,
2016) and data generated during this study. This comparison
yielded a list of 67 core mac genes (Figure S1A). Included in
this list are genes previously ascribed to the mac lineage
including Fcgr1,Mertk, and Cd14 (Gautier et al., 2012; Guilliams
et al., 2016), as well as the TF Zeb2. While this TF has also
recently been identified as a core gene in pre-macs (Mass
et al., 2016), its precise role within the mac lineage has not
been investigated.
Loss of ZEB2 in KCs and AMs Results in an Altered
Phenotype
Given that Zeb2/ mice are embryonic lethal (Higashi et al.,
2002), we utilized CRE-LOX systems to specifically remove
Zeb2 from different mac subsets. Based on Zeb2 expression
(Figure S1A), we first examined the effects of Zeb2 loss in KCs
(higher Zeb2) and AMs (lower Zeb2). Having recently shown
that the C-type lectin, Clec4F, is exclusively expressed byFigure 1. ZEB2 Controls Mac Number and Surface Phenotype
(A) Expression of CD64 and F4/80 by live CD45+Ly6GLy6C- liver cells and Clec4F
number of liver macs per gram of liver and % of total macs expressing Clec4F
***p < 0.001 Student’s t test.
(B) Expression of SiglecF, F4/80, and CD11b by live CD45+CD64+CD11c+ Lung m
CD45+ cells, absolute number, and percentage of CD11b+ and CD11b AMs in I
n = 7–8 per group. *p < 0.05, ***p < 0.001 Student’s t test.
(C and D) t-SNE plot of SC-RNA-seq data of KCs from Clec4f-crexZeb2fl/fl or Z
clusters, assigned groups, and CRE (Red) and CRE+ (Teal) overlay.
(E) tSNE plots showing expression of Zeb2, Siglecf, and Ms4a1 in KCs.
(F) tSNE plots showing expression of Zeb2, Epcam, and Cd101 in AMs.
(G and H) Top 15 DE genes per group based on LogFC per group of KCs (G) or
314 Immunity 49, 312–325, August 21, 2018murine KCs (Scott et al., 2016b) and because KCs are poorly tar-
geted by other available CREs, we generated Clec4f-cre mice.
Crossing these mice to the Rosa26-RFP reporter line revealed
that the majority of RFP-expressing cells were CD64+F4/80+
Clec4F+Tim4+ KCs (Figures S1B–S1E). However, a minor popu-
lation of B cells, despite lacking expression of Clec4F, were
also found to express RFP (Figures S1B–S1E). Despite thisminor
contamination, we crossed the mice to Zeb2fl/fl mice to study the
consequences of deleting Zeb2 in KCs. Analysis of the mac
compartment in the liver of Clec4f-crexZeb2fl/fl mice revealed
that although there was no significant difference in the absolute
number of total CD64+F4/80+ hepatic macs compared with
Zeb2fl/fl controls (Figure 1A), there was a difference in their sur-
face phenotype, with Clec4f-crexZeb2fl/fl mice having a reduced
population of Clec4F+Tim4+ KCs and increased populations of
Clec4F+Tim4 KCs and Clec4FTim4 macs (Figure 1A). This
suggests that ZEB2 might be important for KCs and also high-
lights the importance of examining tissue-specific mac markers.
As ZEB2 appears to play a role in KCs, we next examined if it
also was required by AMs. To remove ZEB2 from AMs, wemade
use of Itgax-cre mice, which efficiently target AMs alongside a
number of other CD11c-expressing cells (Durai and Murphy,
2016). By crossing the Itgax-cre mice to Rosa26-RFP reporters
we confirmed that AMs were efficiently targeted (Figure S1F).
Analysis of the total AM population in Itgax-crexZeb2fl/fl and
Zeb2fl/fl controls revealed a slight reduction in AMs (Figure 1B).
In addition, the loss of Zeb2 from CD11c-expressing cells also
altered the surface phenotype of the remaining AMs with a pro-
portion expressing CD11b in the CRE+ mice (Figure 1B).
Zeb2+/– Macs Are Present in the Lung and the Liver
Tounderstand howZeb2expressionwasaffectingmacs,weper-
formed single-cell RNA sequencing analysis (SC-RNA-
Seq) on total KCs (Clec4F+CD64+F4/80+) and total AMs
(CD64+F4/80+SiglecF+CD11c+) from Clec4f-crexZeb2fl/fl or
Itgax-crexZeb2fl/fl mice compared with Zeb2fl/fl littermate con-
trols. Following pre-processing of the data using the Marioni
pipeline (Lun et al., 2016), poor quality, contaminating, and
actively proliferating cells were excluded (Figure S1G) and
t-SNE plots with both CRE and CRE+ cells combined for KCs
orAMsweregenerated (Figures 1Cand1D).Next,wedetermined
which cells originated from the CRE and CRE+ mice. This anal-
ysis revealed the presence of multiple populations of CRE+ cells
in both the KCs and AMs (Figures 1C and 1D). To begin to assess
what these distinct populations were, we grouped these clusters
based on their genotype. For theKCs, this led to the identification
of 1 group of CRE cells (consisting of clusters 0, 2, 4, 7, referredand Tim4 by total liver macs inClec4f-crexZeb2fl/fl and Zeb2fl/fl mice. Absolute
and Tim4. Data are pooled from four experiments with n = 11–13 per group.
acs in Itgax-crexZeb2fl/fl and Zeb2fl/fl mice. AMs as a percentage of total live
tgax-crexZeb2fl/fl or Zeb2fl/fl mice. Data are pooled from two experiments with
eb2fl/fl mice (C) or AMs from Itgax-crexZeb2fl/fl or Zeb2fl/fl mice (D), showing
AMs (H). See also Figure S1.
toasgroup0)and3distinctgroupsofCRE+cells (cluster6=group
1, cluster 5 = group 2 and clusters 1+3 = group 3) (Figure 1C). For
the AMs, we identified 1 group of CRE cells (group 0; clusters 0,
2, 5, 8), one group ofmixedCRE andCRE+ cells (group 1 = clus-
ter 6), and three groups of CRE+ cells (group 2 = cluster 3, group
3 = clusters 1 + 4 and group 4 = cluster 7) (Figure 1D). Next, we
examined Zeb2 expression between the groups. However, as
the Zeb2fl/fl construction generates a truncated form of the
mRNApossessing a3’ end itwasnot possible todeterminewhich
cells express full-length or floxed mRNA with the 3’ Assay from
10X Genomics. As such, we were unable to conclude based on
Zeb2 expression if these cells had all efficiently deleted Zeb2,
but we identified a group of CRE+ cells that appeared to have
higher Zeb2 expression in each organ (Figures 1E and 1F – group
3 in KCs and AMs). Thus, we next sought to find markers that
could distinguish the different CRE+ populations by flow cytome-
try. To this end, we next determined the differentially expressed
(DE) genes between these groups. For the KCs, this generated
a list of 224 DE genes for group 0, 180 for group 1, 534 for group
2 and 693 for group 3 (Figure 1G & Table S1) and identified
SiglecF and CD20 (Ms4a1) to be markers that could potentially
be used to distinguish between the groups of CRE+ cells (Fig-
ure 1E). For the AMs, this analysis identified 821 DE genes for
group 0, 312 for group 1, 230 for group 2, 929 for group 3 and
883 in group 4 (Figure 1H & Table S2) and identified CD326 (Ep-
cam) and CD101, as two markers which could distinguish be-
tween the groups of CRE+ cells (Figure 1F).
We next examined expression of thesemarkers by flow cytom-
etry. While not expressed by KCs from Zeb2fl/fl mice, SiglecF and
CD20 were found to be expressed by a proportion of KCs in
Clec4f-crexZeb2fl/fl mice at 6 weeks of age (Figure 2A). qRT-
PCR analysis for Zeb2 in SiglecF+, SiglecFTim4+ and
SiglecFTim4 KCs (corresponding to group 3, group 1, and
group 2, respectively) revealed that SiglecF+ KCs had efficiently
deleted Zeb2, while SiglecF cells maintained expression of
Zeb2 comparable with KCs isolated from Zeb2fl/fl control mice
(Figure 2B). Similarly, analysis of EpCam and CD101 expression
in AMs from Itgax-crexZeb2fl/fl mice identified two populations,
those expressing EpCam and CD101 and those negative for
both markers, with only the latter population being observed in
AMs from Zeb2fl/fl mice (Figure 2C). Again, qRT-PCR analysis
determined that only the EpCam+CD101+ AMs had efficiently
deleted Zeb2 (Figure 2D). As there is no good antibody to detect
ZEB2 by flow cytometry, we made use of the prime flow assay,
which measures Zeb2 mRNA expression by flow cytometry to
confirm the qRT-PCR analysis. This confirmed that SiglecF+
KCs and EpCam+ AMs had all efficiently deleted Zeb2 (Figures
2E and 2F). Genomic PCR on the distinct populations of KCs
and AMs identified the SiglecF KCs and EpCam- AMs as being
heterozygous for the Zeb2 deletion (Figures S2A and S2B), indi-
cating that, for anunknownreason, thesecellsareable topreserve
a copy of Zeb2. Returning to the SC-RNA-seq analysis, we could
then identify group 0 in each tissue to be Zeb2+/+ macs from the
CRE mice and group 3 in each tissue to represent bona fide
Zeb2-/- macs from the CRE+ mice. Group 3 in each tissue was
thealso thegroupexpressinghigherZeb2, suggesting that a feed-
back mechanism might be in place in the Zeb2/ macs, where
these cells attempt to increase the expression of the truncated
Zeb2 mRNA. As we have recently shown that Tim4 expressiononKCscorrelatedwith the time these cells have spent in the tissue
(Scott et al., 2016b), we next defined group 1 KCs which lacked
expression of Siglecf and expressed Timd4 as long-lived
Zeb2+/ KCs, while group 2 KCs which lacked expression of
Siglecf and Timd4 but which expressed Cx3cr1 and Ccr2 were
defined as Zeb2+/ putative moKCs that had recently entered
the tissue. In the AMs, the minor population Group 1 contains
both CRE Zeb2+/+ and some CRE+ Zeb2+/ cells. Ingenuity
pathwayanalysisof theDEgenessuggested thisminorpopulation
has an oxidative stress & unfolded protein response signature,
which caused them to fall in a separate cluster (data not shown).
Group 2were identified asZeb2+/ cells lacking expression ofEp-
cam and Cd101 and the minor group 4 were (alongside the main
group 3) also identified as Zeb2/ cells expressing Epcam and
Cd101. Analysis of the DE genes between groups 3 and 4 found
that these cells clustered separately from the group 3 Zeb2/
cells due to their increased expression of MHCII pathway associ-
ated genes (Figure 1H). Thus thesemight represent cells that arise
from monocytes, as increased MHCII expression has been re-
ported on monocyte-derived AMs (van de Laar et al., 2016).
Zeb2+/– Macs Outcompete Their Zeb2–/– Counterparts
with Time
Having identified a Zeb2+/ population of macs amongst both
the AMs and KCs in the CRE+ mice, we next investigated the
maintenance of this population with age. We hypothesized that
if Zeb2 expression was critical for macs, then one would expect
that the Zeb2+/ population would outcompete the Zeb2/
population with time. Thus, we tracked the presence of the
SiglecF+CD20intZeb2/ KC and CD101+EpCam+Zeb2/ AM
populations at 6 and 12 weeks of age. We found that both
Zeb2/ KCs (Figure 2A) and Zeb2/ AMs (Figure 2C) are
reduced at 12 weeks of age. This reduction in SiglecF+ KCs be-
tween 6 and 12 weeks was confirmed by confocal microscopy
(Figure S2C). Moreover, distinct islands of Clec4F+Tim4+
SiglecF and Clec4F+Tim4SiglecF KCs were observed at
both time-points and were increased in size at 12 weeks. This
implied that proliferation of Zeb2+/ KCs may represent a mech-
anism by which these cells expand with age. To investigate this,
we examined expression of the cell proliferation marker Ki-67 by
the different KC populations in Clec4f-crexZeb2fl/fl mice. This
analysis showed that while Zeb2+/+ KCs in littermate
controls proliferated lowly, SiglecF Zeb2+/ KCs from Clec4f-
crexZeb2fl/fl mice proliferated significantly more. Conversely,
Zeb2/ SiglecF+ KCs from Clec4f-crexZeb2fl/fl mice were
restricted in their ability to proliferate (Figures S2D and S2E). In
the lung, Ki-67 staining also revealed that Zeb2/ EpCam+
AMs did not proliferate to any great extent, while their Zeb2+/
EpCam counterparts in Itgax-crexZeb2fl/fl proliferated at signif-
icantly increased rates compared with EpCam Zeb2+/+ AMs in
littermate controls (Figures S2F and S2G). Given this reduced
proliferation by Zeb2/ macs, we next sought to determine
whether this was due to a defect in their ability to proliferate.
Thus, we administered CSF-1Fc or PBS to Clec4f-crexZeb2fl/fl
mice, a procedure that has been described to induce KC prolif-
eration (Gow et al., 2014). Zeb2-/- KCs proliferated efficiently in
response to CSF-1 (Figure S2H) indicating that loss of Zeb2
does not block the proliferative capacity of macs, but rather
may be required for their maintenance.Immunity 49, 312–325, August 21, 2018 315
AC
B
D
E F
G IH
Figure 2. Zeb2–/– Macs Are Lost with Time
(A) SiglecF and CD20 expression by Clec4F+ KCs at 6 and 12 weeks of age compared with Zeb2fl/fl controls. Data are from one or two experiments with n = 7–10
per group. ***p < 0.001 one-way ANOVA with Bonferroni post-test.
(B) Relative expression of Zeb2mRNAnormalized to b-actin as determined by qPCRof sorted SiglecF+ and SiglecFKCs comparedwith CRE controls. Data are
pooled from one experiment with n = 5–7 per group. ***p <0.001 one-way ANOVA with Bonferroni post-test.
(C) Expression and percentage of EpCam and CD101 by AMs at 6 and 12 weeks of age compared with Zeb2fl/fl controls. Data are pooled from one or two
experiments with n = 5–11 per group.
(D) Relative expression of Zeb2 mRNA normalized to b-actin as determined by qPCR of sorted EpCam+ and EpCam AMs compared with CRE control AMs.
Data are from one experiment with n = 5–7 per group.
(E) Expression of Zeb2 mRNA and SiglecF in KCs from Zeb2fl/fl and Clec4f-crexZeb2fl/fl mice compared with label probe only control. Data are from one
experiment with n = 5–6 per group.
(F) Expression of Zeb2mRNA and EpCam in AMs from Zeb2fl/fl and Itgax-crexZeb2fl/fl mice compared with label probe only control. Data are from one experiment
with n = 4–5 per group.
(G) Schematic of experimental set up.
(H) Percentage SiglecF+CD20int KCs amongst total CD45.2+ KCs and (I) percentage CD101+EpCam+ AMs amongst total CD45.2+ AMs at indicated time points
(days) post the last dose of tamoxifen. Data are pooled from two experiments with n = 4–7 per time-point. ***p < 0.001, one-way ANOVAwith Bonferroni post-test.
In (H) and (I) each time point is compared to the previous time point and controls are pooled from donor macs frommice administered corn oil and host macs from
mice administered tamoxifen. See also Figure S2.Loss of Zeb2 Leads to Mac Disappearance
To examine the idea that loss of Zeb2 induces mac disappear-
ance, we generated BM chimeras in which CD45.1+ mice
were irradiated and reconstituted with congenic CD45.2+316 Immunity 49, 312–325, August 21, 2018Rosa26-creert2xZeb2fl/fl BM. Chimeras were made to prevent
death of the animals due to Zeb2 loss in non-hematopoietic cells.
6 weeks later, mice were administered tamoxifen for 5 days by
oral gavage to induce CRE-mediated loss of Zeb2. KCs and
AMs were then examined 2, 6, 20, 34, and 48 days after the last
dose of tamoxifen and expression of CD101 and EpCam (Lung
AMs) or SiglecF and CD20 (Liver KCs) in donor-derived
CD45.2 cells was assessed (Figure 2G). Controls include both
CD45.2 cells from control mice that were not treated with tamox-
ifen and host CD45.1+WT cells frommice treated with tamoxifen
(Figures 2H and 2I). In the liver, 12.27% ± 3.88% of donor-
derived KCs expressed SiglecF and CD20 2 days post the last
dose of tamoxifen and this rose modestly at day 6. 20 days
post the last dose of tamoxifen, SiglecF+CD20+ KCs could no
longer be detected in the liver implying that the Zeb2/ KCs
had disappeared (Figure 2H). This disappearance of Zeb2/
KCs was confirmed by the PrimeFlow assay, as by day 20 all
Zeb2/ KCs were lost (Figure S2I). In the lung, 2 days post
administration of tamoxifen 26.1% ± 4.23% of CD45.2 donor
AMs expressed CD101 and EpCam. This further increased to a
maximum of 56.4% ± 2.02% six days post the last dose of
tamoxifen. At all subsequent time points examined this dropped
continuously reaching 10.78%± 3.25%at day 48 (Figure 2I). This
disappearance of Zeb2/ AMs was also confirmed using the
PrimeFlow assay (Figure S2J). Taken together, these results
demonstrate that ZEB2 is strictly required for the continued pres-
ence of macs in tissues and suggest that loss of ZEB2may result
in impaired mac maintenance.
Loss of Zeb2 from KCs but Not AMs, Results in Their
Replenishment from BM
We next investigated whether the Zeb2/ macs were being re-
plenished from the BM or if mac numbers weremaintained solely
by local proliferation of Zeb2+/ counterparts. To examine this,
we generated partially-protected chimeras, in which Clec4f-
crexZeb2fl/fl, Itgax-crexZeb2fl/fl mice or Zeb2fl/fl littermate con-
trols were irradiated with their livers or lungs protected and
reconstituted with congenic CD45.1WT BM (Figure 3A). 4 weeks
later, we examined the proportion of CD45.1+ cells within the
blood monocytes and KCs in the liver (defined as Clec4F+) or
AMs in the lung (defined as CD11c+SiglecF+). As the mice
were partially protected from irradiation, the animals were be-
tween 30%–50% chimeric (calculated by examining chimerism
in blood Ly6Chi monocytes). Comparison of the chimerism be-
tween the blood monocytes and liver KCs found that KCs were
chimeric (Figure 3B); however, lung AMs displayed very low
chimerism (Figure 3C). To further investigate how Zeb2/
macs were being lost and replaced by Zeb2+/ counterparts,
we next questioned whether themacs were dying in the absence
of ZEB2. We examined expression of a number of genes associ-
ated with distinct cell death pathways in our SC-RNA-Seq anal-
ysis. Although a number of these genes were either not
expressed or their expression was not altered in Zeb2/
macs, we did observe thatRipk3, Il1a, and Il1bwere upregulated
in Zeb2/ KCs and AMs, suggesting that the loss of Zeb2might
result in mac death by necroptosis (Figures 3D and 3E). More-
over, we evaluated the expression of RIPK3 and phosphorylated
MLKL (pMLKL) by cells recovered from bronchioalveolar lavage
(BAL) fluid from the Rosa26-creert2xZeb2fl/fl chimeras 27 days
post the last dose of tamoxifen and compared them to chimeras
which received corn oil as a control. Total BAL cells were used to
prevent induction of cell death during the extensive enzymatic
digestions required to isolate macs from tissues. This analysisrevealed a trend (p = 0.06) towards increased pMLKL (Figure 3F).
Taken together, our results demonstrate that ZEB2 is critical for
the maintenance of KCs and AMs, with Zeb2/macs being lost
from the tissue with time. Furthermore, it suggests that Zeb2/
macs might be lost through necroptotic cell death.
Zeb2 Controls Tissue-Specific Identity of Lung and
Liver Macs
Having identified the distinct populations of KCs and AMs pre-
sent in the SC-RNA-seq data, we next examined the mechanism
through which loss of Zeb2 induces the mac disappearance. As
loss of Zeb2 affected both KCs and AMs, we first looked for the
DE genes that were conserved between both mac populations.
However, this demonstrated that the majority of DE genes
were unique to either the KC (459 DE genes) or AM (701 DE
genes) population (Figure 3G). As the gene-expression profiles
of different tissue macs have been shown to be highly heteroge-
neous and ZEB2 is known for its role in altering cellular identities
in EMT, we next hypothesized that ZEB2 might control the tis-
sue-specific identities of the different mac populations, with its
loss rendering themacs less suited to their niche resulting in their
subsequent loss. To examine this, we investigated how the core
KC and AM transcriptional profile changed in the absence of
ZEB2. As additional mac populations have been sequenced
since the core profiles of these two macs were described (Gaut-
ier et al., 2012; Scott et al., 2016b), we first redefined these pro-
files. Thus, we compared the transcriptional profile of AMs, KCs,
microglia, peritoneal macs, colonic macs (CMs), and splenic red
pulpmacs (SMs) (Lavin et al., 2014) and identified the genes spe-
cific to the KCs and AMs (Figure S3). As there was considerable
overlap between the transcriptional profiles of KCs and SMs,
SMs were excluded when defining the core profile of KCs and
vice versa. Furthermore, as these core lists were defined on
the basis of bulk RNA seq data, we performed an additional con-
trol whereby to be a core gene, it must be expressed in at least
20% of our Zeb2fl/fl KCs and AMs profiled by SC-RNA-seq (Fig-
ure S3). This was required because previously reported core
mac gene lists contained genes expressed by contaminating
cells (Lynch et al., 2018). We next compared how expression
of the top core genes were altered upon loss of ZEB2 and found
that there were numerous changes to the core profiles of both
mac populations with 60% of the KC tissue-specific genes and
72% of the AM tissue-specific genes affected by the loss of
Zeb2 (Figures 3H and 3I), suggesting ZEB2 might play a role in
maintaining the tissue-specific identities of these macs.
Loss of KC Identity in Absence of ZEB2 Is in Part Due to
the Loss of LXRa
We next examined the mechanism through which ZEB2 could
control mac tissue-specific identities. For this, we focused on
the KCs. The tissue-specific identity of macs has been proposed
to be controlled by a small set of tissue-specific TFs (Lavin et al.,
2014). Nr1h3 (encoding LXRa) was reported to be highly ex-
pressed by KCs (Mass et al., 2016) and was among the list of
DE core KC identity genes in KCs lacking Zeb2 (Figure 3H).
Thus, we hypothesized, that ZEB2 might control KC identity by
regulating LXRa expression. LXRa was previously reported to
be dispensable for KC development and survival, but this was
based solely on F4/80 and CD68 expression (A-GonzalezImmunity 49, 312–325, August 21, 2018 317
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Figure 3. ZEB2 Controls Tissue Identity of KCs and AMs
(A) Schematic of experimental set up.
(B) Expression of CD45.1 (donor) and Tim4 in total Clec4F+ KCs in Clec4f-crexZeb2fl/fl chimeras. Percentage of total chimerism of KCs in Zeb2fl/fl and Clec4f-
crexZeb2fl/fl mice. Data are pooled from two experiments with n = 6–10 per group.***p < 0.001 Student’s t-test.
(C) Expression of CD45.1 (donor) and CD45.2 (host) in total lung AMs in Itgax-crexZeb2fl/fl mice. Percentage of total chimerism of AMs in Zeb2fl/fl and Itgax-
crexZeb2fl/fl mice. Data are pooled from two experiments with n = 5–8 per group. NS; non-significant. Student’s t-test. Percentage total chimerism calculated as
ratio over the chimerism in blood Ly6Chi monocytes in the same mouse.
(D and E) Heatmap of expression of cell death-associated genes per group of KCs (D) or AMs (E) from SC-RNA-seq data.
(F) Representative western blots (n = 2) for RIPK3, pMLKL, and Tubulin expression by total BAL cells isolated from CD45.1 mice that were irradiated (8 Gy) and
reconstituted with Rosa26-creert2xZeb2fl/fl BM. 33 weeks post reconstitution, mice were fed 5 mg tamoxifen or corn oil as a control for 5 days. 27 days after the
last dose, mice were sacrificed and BAL fluid isolated. BAL fluid from 3 or 4 mice was pooled per replicate and 150,000 cells were used per lane. Ratio of band
intensity was calculated using ImageJ. Data are pooled from two experiments with n = 6–8 per group. Student’s t-test was used to calculate indicated p values.
(G) Venn diagram showing DE genes specific to Zeb2/ KCs (group 3), Zeb2/ AMs (group 3), or shared between both mac populations.
(H and I) Heatmap showing expression of top core genes across KC (H) or AM (I) groups from SC-RNA-seq data. Genes in red are significantly differentially
expressed. See also Figure S3.
318 Immunity 49, 312–325, August 21, 2018
AB
C
E
D
HF G
(legend on next page)
Immunity 49, 312–325, August 21, 2018 319
et al., 2013). Therefore, we decided to revisit the effects of loss of
Nr1h3 on KCs. We crossed Nr1h3fl/fl mice with Clec4f-cre mice
generating Clec4f-crexNr1h3fl/fl mice. This confirmed that loss
ofNr1h3 did not affect the proportion or absolute number of total
hepatic CD64+F4/80+ macs (Figure 4A). However, as for the loss
of Zeb2, it altered the proportions of cells expressing Clec4F and
Tim4 (Figure 4B). Protected chimeras demonstrated that in the
absence of Nr1h3, KCs were being replaced from a BM source
(Figure 4C). As these data suggest that ZEB2 might function to
control KC identity through maintaining LXRa expression, we
next determined whether the effect of Zeb2 loss on the KCs tran-
scriptome might reflect loss of LXRa-dependent genes. Thus,
we performed SC-RNA-seq of KCs from Clec4f-crexNr1h3fl/fl
mice and Nr1h3fl/fl littermate controls. Following the same pre-
processing as above (Figure S1G), we identified 2 main groups
of KCs in the t-SNE plot of CRE and CRE+ cells. Group 0 con-
sisted of Nr1h3+/+ KCs from the CRE mice and group 1 con-
sisted of Nr1h3/ KCs from the CRE+ mice (Figure 4D). Mice
lacking only one copy of LXRa in their KCs (Clec4f-crexNr1h3fl/+)
did not display a similar phenotype to Clec4f-crexNr1h3fl/fl mice,
suggesting no obvious effect ofNr1h3 haploinsufficiency on KCs
(Figure S4A). Analysis of the DE genes between Nr1h3+/+ KCs
and Nr1h3/ KCs identified 451 DE genes (Figure 4E and Table
S3) and many of these DE genes were also core KC genes
including Cdh5, Pcolce2, Kcna2, C6, and Il18bp (Figure 3H)
and were similarly lost upon loss of Zeb2 (Figure 4E). Moreover,
we were able to confirm this downregulation in both Zeb2/ and
Nr1h3/ KCs by flow cytometry (Figures 4F and 4G) or qRT-
PCR (Figures S4B and S4C). As loss of ZEB2 and LXRa led to
replacement of the KCs from the BM, we noticed that a number
of the DE genes were also related to origin of the KCs. To remove
any DE genes associated with mac origin and hence only
examine DE genes resulting from the loss of LXRa or ZEB2, we
used our previously published data (Scott et al., 2016b) and iden-
tified any DE genes between moKCs from KC-DTRmice 15 days
post treatment with DT and embryonic KCs (Figure S4D). Com-
parison of the overlap between the remaining non-origin related
DE genes associated with the Zeb2/ and Nr1h3/ KCs iden-
tified that 203 of the 435 DE genes in Nr1h3/ KCs were
conserved in both datasets (Figure 4H), including many of the
liver-specific core KC genes. Crucially, while there is overlap be-
tween the two genotypes, it is not 100%, indicating that loss of
LXRa is not solely responsible for all the DE genes identified in
Zeb2/ KCs. Nonetheless, loss of LXRa is sufficient to recapit-
ulate the loss of KC identity and the disappearance and replen-Figure 4. Loss of LXRa from KCs Recapitulates Main Features of Zeb2
(A) Expression of CD64 and F4/80 by live CD45+Ly6GLy6C liver cells inClec4f-
cells and absolute number per gram of liver.
(B) Expression of Clec4F and Tim4 by total liver macs in Clec4f-crexNr1h3fl/fl and
are pooled from two experiments with n = 12 per group. ***p < 0.001 Student’s t
(C) Percentage total chimerism of total Clec4F+ KCs in Nr1h3fl/fl and Clec4f-crex
***p < 0.001; Student’s t-test.
(D) t-SNE plot of SC-RNA-Seq data from KCs from Clec4f-crexNr1h3fl/fl and Nr1h
overlay.
(E) Heatmaps showing top DE genes (15 downregulated, 15 upregulated) based
indicated groups of KCs from Zeb2fl/fl and Clec4f-crexZeb2fl/fl mice.
(F andG) Histogram andMFI of CD55 expression in (F) Zeb2+/+ (Zeb2fl/fl), SiglecF+
Nr1h3+/+ (Nr1h3fl/fl) and Nr1h3/ KCs from Clec4f-crexNr1h3fl/fl mice.
(H) Venn diagram showing DE genes specific to Zeb2/ KCs, Nr1h3/ KCs, or
320 Immunity 49, 312–325, August 21, 2018ishment of KCs by BM cells observed in Clec4f-crexZeb2fl/fl
mice. Taken together, these data demonstrate that ZEB2 con-
trols KC identity at least in part by regulating LXRa expression.
ZEB2 Functions across the Mac Lineage to Maintain the
Tissue-Specific Identities
We next investigated if ZEB2 was required across the mac line-
age. To this end, we crossed the Zeb2fl/fl mice to the Fcgr1-cre
mice recently generated by Bernard Malissen (Figure S5).
Fcgr1-crexRosa26-RFP mice revealed that SMs, microglia, and
CMs were efficiently targeted with this CRE (Figures S5A–S5D).
However, a number of other immune cells are also targeted in
these mice. This includes CD64 B cells, T cells, cDC1s, and
cDC2s (Figure S5A). Fcgr1-crexZeb2fl/fl mice had no change in
the proportion or number of the total SM population defined as
LinCD64+F4/80+ (Figure 5A), but a proportion of these macs
gained expression of CD11b in the absence of Zeb2 (Figure 5A).
In addition, we observed a reduction in absolute number of mi-
croglia (Figure 5B) and Zeb2/microglia were found to upregu-
late their expression of CD11c (Figure 5B). To examine whether
ZEB2also functions in themaintenance of BMmonocyte-derived
macs, we next examinedwhether Zeb2was also required in CMs
which are constantly replaced by BM monocytes during adult-
hood along a trajectory dubbed the ‘‘monocyte-waterfall’’ (Bain
et al., 2013; 2014; Tamoutounour et al., 2012). Analysis of the
monocyte-waterfall in Fcgr1-crexZeb2fl/fl mice identified a
reduction in the proportion and number ofmature CMs alongside
an increase in the proportion and number of Ly6C+MHCII+ transi-
tioning monocytes (Figure 5C).
To determine whether these changes reflected altered tissue-
specific identities of these macs, we next performed SC-RNA-
seq analysis. Following the same pre-processing as above (Fig-
ure S1G), we used expression of Zeb2, Ms4a1, Siglecf, Cd101,
or Epcam to identify Zeb2/ macs in the spleen, brain, and co-
lon (Figure 6). Note that, as was observed for the lung and liver,
the Zeb2/ macs in the spleen, brain, and colon expressed
higher Zeb2, again suggesting a feedback mechanism in the
Zeb2/macs (Figure 6). We identified threemain groups of cells
in the SMs (group 0; Zeb2+/+macs from the CREmice, group 1;
presumably Zeb2+/ macs from the CRE+ mice clustering close
to the Zeb2+/+ macs from the CRE mice and group 2; Zeb2/
macs from the CRE+ mice clustering separately and expressing
higher Zeb2, Siglecf, and Epcam) (Figure 6A). In addition, we
identified 2 groups of cells in the microglia (group 0; Zeb2+/+
macs from the CRE mice and group 1; Zeb2/ macs from–/– KCs
crexNr1h3fl/fl and Nr1h3fl/fl mice. Liver macs as a percentage of total live CD45+
Nr1h3fl/fl mice and percentage of total macs expressing Clec4F and Tim4. Data
test.
Nr1h3fl/fl mice. Data are pooled from two experiments with n = 6–8 per group.
3fl/fl mice, showing clusters, assigned groups and CRE (Red) and CRE+ (Teal)
on LogFC in KCs with loss of LXRa and expression of the same genes by the
Zeb2/KCs, and SiglecF Zeb2+/KCs fromClec4f-crexZeb2fl/fl mice and (G)
shared between both mac populations. See also Figure S4.
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Figure 5. Loss of ZEB2 Affects Mac Phenotype and/or Number across Tissues
(A) Expression of CD64, F4/80 andCD11b by live CD45+Ly6G-CD64+Ly6CMHCIISMs in Fcgr1-crexZeb2fl/fl andZeb2fl/fl mice. SMs as a percentage of total live
CD45+ cells, absolute number and percentage of CD11b+ and CD11b SMs in Fcgr1-crexZeb2fl/fl or Zeb2fl/fl mice.
(B) Expression of CD64, F4/80, CD11c, and CD11b by live CD45int microglia in Fcgr1-crexZeb2fl/fl and Zeb2fl/fl mice. Microglia as a percentage of total live CD45+
cells, absolute number and percentage of CD11c+ and CD11c microglia in Fcgr1-crexZeb2fl/fl or Zeb2fl/fl mice.
(C) Expression of Ly6C and MHCII (monocyte waterfall) by live CD45+CD11b+Ly6GSiglecF non cDCs in Fcgr1-crexZeb2fl/fl and Zeb2fl/fl mice. Percentage of
live CD45+ and absolute number of Ly6C+MHCII, Ly6C+MHCII+, and Ly6CMacs in Fcgr1-crexZeb2fl/fl or Zeb2fl/fl mice. Data are pooled from two experiments
with n = 8–11 per group. *p < 0.05, **p < 0.01, ***p < 0.001 Student’s t test. See also Figure S5.the CRE+mice expressing higher Zeb2, Siglecf, andCd101) (Fig-
ure 6B). While we performed the SC-RNA-seq analysis on total
CMs (Figure 6C), we found these could be divided into two
main groups of cells, those expressing high Cd74 (coding for
theMHCII-associated invariant chain),H2-Aa,H2-Eb1, and Itgax
(coding for CD11c) and those expressing low Cd74 (Figure 6C).
As all the Zeb2/ cells (identified by higher Zeb2, Ms4a1, and
SiglecF) expressed high Cd74 (Figures 6D) and as the gene-
expression profiles of the Cd74hi and Cd74lo Zeb2+/+ subsets
of CMs from CRE- mice were distinct (Figure S6), we chose to
focus our analysis on the comparison between Cd74hi Zeb2+/+
macs and Cd74hi Zeb2/ macs (Figure 6D). Within CD74hi
macs, we identified 2 main groups of cells (group 0; containinga mix of Zeb2+/+ macs from the CRE mice and presumably
Zeb2+/ macs from the CRE+ mice clustering together, and
group 1; containing Zeb2/macs from the CRE+ mice express-
ing higher Zeb2, Ms4a1, and SiglecF) (Figure 6D).
To examine the effects of loss of ZEB2 on mac identity, we
next determined the core profiles of these macs as described
above (Figures S7A–S7C) and examined the expression of these
identity genes in the Zeb2/macs. As for the liver and lung, this
revealed that the core profiles of the different macs were altered
in the absence of Zeb2 (60% in SMs and microglia and 76% in
CMs; Figures 7A–7C, with indicated groups from Figure 6).
Consistent with the data from the liver and lung (Figures
2G–2I), Zeb2/ SMs were also found to disappear in mice inImmunity 49, 312–325, August 21, 2018 321
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Figure 6. Loss of Zeb2 Results in Altered Transcriptome across Mac Lineage
(A and B) t-SNE plot of SC-RNA-seq data from SMs (A) and microglia (B) sorted from Fcgr1-crexZeb2fl/fl and Zeb2fl/fl mice, showing clusters of macs, assigned
groups and CRE (Red) and CRE+ (Teal) overlay and expression of indicated genes.
(C) t-SNE plot of SC-RNA-seq data from total CMs from Fcgr1-crexZeb2fl/fl and Zeb2fl/fl mice, showing clusters of macs and Cd74, Itgax, H2-Aa, and H2-Eb1
expression.
(D) t-SNE plot of SC-RNA-seq data from Cd74hi CMs from Fcgr1-crexZeb2fl/fl and Zeb2fl/fl mice, showing clusters, assigned groups and CRE (Red) and CRE+
(Teal) overlay and expression of indicated genes. See also Figure S6.which Zeb2 loss was induced by tamoxifen administration (Fig-
ures S7D and S7E). The brain and colon were unfortunately not
assessed but the conserved effects in the liver, lung, and spleen
coupled with the reduced population of microglia and increased
turnover of CMs strongly suggests that loss of Zeb2 inducesmac
disappearance across tissues.
To further confirm that the loss of ZEB2 results in tissue-spe-
cific changes, we examined the overlap between the DE genes in
the 5 tissues (Tables S1, S2, S4, S5 and S6) and generated a sin-
gle t-SNE file containing all Zeb2+/+ and Zeb2/macs from the 5
organs (Figure 7D). This demonstrated that loss of Zeb2 did not
direct the cells from each tissue along a single component in the
tSNE plot, suggesting the changes were predominantly tissue-
specific. Additionally, we found that the majority of DE genes
were specifically altered in only one of the 5 tissues (Figure 7E)
with only 32 DE genes being shared by all tissues (Figures 7E
and 7F). Taken together, these data highlight that loss of Zeb2
has a striking tissue-specific effect on mac identity.322 Immunity 49, 312–325, August 21, 2018DISCUSSION
TFs are at the core of lineage specification and commitment
through regulation of gene expression. TFs can function at
various stages in a cell, during development and/or in the main-
tenance of the terminally-differentiated cells, as well as in con-
trolling specific cellular functions. While a number of TFs have
recently been identified in specific mac populations including
ID3 in KCs (Mass et al., 2016), PPARg in AMs (Schneider et al.,
2014) and GATA6 in peritoneal macs (Lavin et al., 2014; Okabe
and Medzhitov, 2014), the TFs governing the entire mac lineage
aside from PU.1 remain to be fully investigated. Here we report
that Zeb2 is highly expressed inmacs across tissues. In addition,
Zeb2 has been reported to already be expressed in the embry-
onic pre-macs (Mass et al., 2016). Our data indicate that ZEB2
was required to maintain the cellular identity of macs with its
loss leading to their disappearance from all tissues studied.
Therefore, just as ZEB2 controls cell identity in EMT (Brabletz
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Figure 7. Loss of ZEB2 Results in Loss of
Mac Tissue-Specific Identity across Tissues
(A–C) Heatmap showing expression of top core SM
(A), microglia (B), or Cd74hi CM (C) genes across
indicated groups from SC-RNA-Seq analysis.
Genes in red are significantly differentially ex-
pressed.
(D) t-SNE showing all macs sequenced by SC-
RNA-seq from the indicated five tissues. Zeb2/
macs are shown in bold color, Zeb2+/+ or Zeb2+/
macs are shown in faded color. Open circles
represent cells arising from CRE mice while filled
circles are those isolated from CRE+ mice (Fcgr1-
cre, Itgax-cre, or Clec4f-cre).
(E) Venn Diagram detailing overlap of DE genes
between all five tissue mac populations in the
absence of Zeb2.
(F) Heatmap showing 32 DE genes conserved
across all five tissue mac populations. See also
Figure S7.and Brabletz, 2010) it is essential for the maintenance of mac
identities across tissues.
SC-RNA-seq analysis of the different mac populations re-
vealed that Zeb2 was often not efficiently deleted in all macs us-
ing the three distinct CRE models we employed, with Zeb2+/
populations being observed in all organs except the brain. The
mechanism by which some Zeb2+/ macs retain one unfloxed
Zeb2 allele remains unclear and requires further investigation.
Zeb2/ macs were distinguished from Zeb2+/ counterparts
within the same mouse on the basis of their phenotype. KCs ex-
pressed SiglecF and CD20 (encoded byMs4a1) following loss of
Zeb2, while AMs expressed CD101 and EpCam. These markers,
although not conserved between all the mac populations, were
conserved in a number of the populations and with Zeb2-defi-
cient cDC2s (Scott et al., 2016a) suggesting that ZEB2 expres-Imsion might be linked with the repression
of a set of surface receptors. However, it
was not through these markers that we
first determined an effect of loss of
ZEB2 expression in KCs and AMs.
Rather, we noted a loss of Tim4 expres-
sion in Clec4F+ KCs and an increase in
Clec4F macs within total F4/80+CD64+
hepatic macs, an increase in CD11b
expression in AMs and SMs, an increase
in CD11c in microglia and an increased
turnover rate of CMs. This highlights
the importance of looking at tissue-spe-
cific mac markers and not just F4/80
or CD64 when examining different mac
populations.
In terms of understanding mac
ontogeny, we recently proposed the
mac niche hypothesis (Guilliams and
Scott, 2017). We suggested that niche
availability and niche accessibility would
be the two main factors determining
mac ontogeny. Loss of ZEB2 withinmature macs induces mac disappearance, which creates niche
availability. We found that these lost macs are replaced (in
part) by cells of BM origin (likely BM monocytes) in the liver but
not to any great extent in the lung. It is worth noting, however,
that we do see a small population of MHCII-expressing AMs in
the SC-RNA-seq analysis and found few BM-derived cells in
the chimeras, indicating that a minor fraction of AMs could be re-
placed by monocytes. This major replacement of KCs but minor
replacement of AMs is in linewith our niche hypothesis (Guilliams
and Scott, 2017) as only the liver mac niches are accessible to
progenitors circulating in the blood as liver KCs reside in the
bloodstream of the liver sinusoids while the AM niches are pro-
tected by the lung epithelial barrier. However, we only see a small
reduction in total AM cell number following loss of ZEB2 despite
there being very limited replenishment from the BM. This ismunity 49, 312–325, August 21, 2018 323
because the Zeb2+/ AMs present were sufficient to refill the
niche with time through local proliferation. Proliferation of
Zeb2+/ macs also contributed to mac maintenance in the liver.
The dual mechanism of replacement in the liver via both BM pre-
cursors and local proliferation is consistent with our previous
study whereby partial depletion of KCs using the Clec4f-Dtr
mice led to reconstitution of the mac pool via the same two
mechanisms (Scott et al., 2016b). This highlights the crucial
requirement for ZEB2 within the mac lineage as Zeb2/ macs
are outcompeted from the mac niche, regardless of the repopu-
lation mechanism.
How does ZEB2 function to maintain the mac lineage? We
propose that loss of ZEB2 leads to loss of the mac tissue-spe-
cific identities. In KCs, loss of Zeb2 leads to loss of Nr1h3, sug-
gesting that one mechanism of action of ZEB2 is to maintain the
expression of TFs driving the tissue-specific identities of the
different mac populations. We found that loss of LXRa in KCs
recapitulated the main traits of Zeb2/ KCs including loss of
KC identity and disappearance from the liver, suggesting that
downregulation of LXRa is at least in part responsible for the
phenotype of Zeb2/ KCs. The mechanisms underlying the
control of tissue-specific identities by Zeb2 in other organs
remain to be investigated. However, the reduced expression of
the TF Cebpb in the Zeb2/ AMs, a TF recently reported to be
essential for AMs (Cain et al., 2013), suggests that loss of Zeb2
might control mac identity globally by regulating expression of
tissue-specific TFs in the different macs, and we are currently
investigating this.
In conclusion, our study highlights that Zeb2 expression is a
defining characteristic of the mac lineage. ZEB2 is crucial for
the maintenance of macs, with its absence leading to changes
in their transcriptional profiles, including loss of roughly 60% of
their tissue-specific identities potentially through the decreased
expression of tissue-specific TFs, such as LXRa in KCs. This loss
of identity inevitably results in mac disappearance, possibly due
to death by necroptosis, identifying ZEB2 as a crucial TF in mac
biology and LXRa as a master TF in KCs.STAR+METHODS
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Antibodies
CD64 – BV711 Biolegend 139311; RRID: AB_2563846
F4/80 - Biotin eBioscience 13-4801-85; RRID: AB_466658
CD11c – PE-eFluor 610 eBioscience 61-0114-82; RRID: AB_2574530
CD11b – PE-Cy7 BD Biosciences 552850; RRID: AB_394491
CD11b – Horizon V450 BD Biosciences 560455; RRID: AB_1645266
Clec4F - Unconjugated R & D Systems AF2784; RRID: AB_2081339
SiglecF - PE BD Biosciences 552126; RRID: AB_394341
SiglecF – BUV395 BD Biosciences 740280
SiglecF – Unconjugated BD Biosciences 552125; RRID: AB_394340
Ly6G - FITC BD Biosciences 551460; RRID: AB_394207
Ly6G - PE BD Biosciences 551461; RRID: AB_394208
Ly6G - APC BD Biosciences 560599; RRID: AB_1727560
CD26 - FITC BD Biosciences 559652; RRID: AB_397295
CD45 – BV510 Biolegend 103138; RRID: AB_2563061
MHCII – AF700 eBioscience 56-5321-82; RRID: AB_494009
Tim4 – PerCP-eFluor710 eBioscience 46-5866-82; RRID: AB_2573781
Tim4 – AF647 Biolegend 130008; RRID: AB_2271648
Tim4 - PE eBioscience 12-5866-82; RRID: AB_1257163
Ly6C – eFluor450 eBioscience 48-5932-82; RRID: AB_10805519
Ly6C - FITC BD Biosciences 553104; RRID: AB_394628
CD20 - PE eBioscience 12-0203-82; RRID: AB_2572552
CD101 - PE eBioscience 12-1011-82; RRID: AB_1210728
CD326 (EpCam) – PE-Cy7 Biolegend 118216; RRID: AB_1236471
RFP – Unconjugated Rockland 600-401-379; RRID: AB_2209751
F4/80 - Unconjugated ABD Pharmingen Serotec MCA497R; RRID: AB_323279
CD55 – PE Biolegend 131803; RRID: AB_1279267
F4/80 – BV786 Biolegend 123141; RRID: AB_2563667
Chemicals, Peptides, and Recombinant Proteins
BV605 – Streptavidin BD Biosciences 563260
Donkey Anti-Goat IgG – AF647 Thermo Fisher A-21447; RRID: AB_2535864
Donkey Anti-Goat IgG – AF488 Thermo Fisher A-11055; RRID: AB_2534102
DAPI Invitrogen D1306; RRID: AB_2629482
Donkey Anti-Rat Cy3 Jackson Immunoresearch 712-166-153; RRID: AB_2340669
Donkey Anti-Rabbit - AF647 Invitrogen A21247; RRID: AB_141778
Tamoxifen Sigma-Aldrich T5648-1G
Corn Oil Sigma-Aldrich C8267-500ML
Sensifast SYBR no Rox mix Bioline BIO-98020
Saponin Sigma-Aldrich 4521
Donkey Serum Abcam ab7475
Rat Serum Sigma Aldrich R9759
FoxP3 Transcription factor staining buffer kit eBioscience 00-5523-00
Critical Commercial Assays
PrimeFlow RNA Assay Thermo Fisher 88-18005-210
Zeb2 probes Type 1 for PrimeFlow Thermo Fisher PF-210
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RNeasy Micro Plus kit QIAGEN 74034
Sensifast cDNA synthesis kit Bioline BIO-65054
Allin Red Taq HighQu HQ.HSM0305
CSF1fc David Hume/Clare Pridans (Gow et al., 2014)
Deposited Data
RAW and analyzed data GEO GSE117081
Experimental Models: Organisms/Strains
Mouse: Zeb2fl/fl Huylebroeck Lab (Higashi et al., 2002)
Mouse: Clec4f-cre CIPHE, Marseille, France This study
Mouse: Itgax-cre Jackson Laboratories Stock No: 008068
Mouse: Rosa-RFP Malissen Lab (Luche et al., 2007)
Mouse: Rosa-26-creert2 Jackson Laboratories Stock No: 008463
Mouse CD45.1 Harlan Stock: B6.SJL-PtprcaPep3b/BoyJ
Mouse Fcgr1-cre Bernard Malissen, Marseille, France This study
Mouse Nr1h3fl/fl Institut de la Souris, GIE, France (A-Gonzalez et al., 2013; Zhang et al., 2012)
Oligonucleotides
b-Actin qPCR FWD: GCTTCTAGGCGGACTGTTACTGA
b-Actin qPCR REV: GCCATGCCAATGTTGTCTCTTAT
Zeb2 qPCR FWD: CCAGAGGAAACAAGGATTTCAG
Zeb2 qPCR REV: AGGCCTGACATGTAGTCTTGTG
Zeb2 common (Flox or deletion) PCR GGGGTCTCCACAGAGTTGAT
Zeb2 deletion PCR TGTTTGTTTTGGAGACCGGA
Zeb2 flox PCR CTTGCAGTTTGGGCATTCGT
Nr1h3 qPCR FWD CAAGGGAGCACGCTATGTCTG
Nr1h3 qPCR REV GGACACCGAAGTGGCTTGAG
Cd5l qPCR FWD GAGGACACATGGATGGAATGT
Cd5l qPCR REV ACCCTTGTGTAGCACCTCCA
Apoc1 qPCR FWD TCCTGTCCTGATTGTGGTCGT
Apoc1 qPCR REV CCAAAGTGTTCCCAAACTCCTT
Cdh5 qPCR FWD CACTGCTTTGGGAGCCTTC
Cdh5 qPCR REV GGGGCAGCGATTCATTTTTC
Software and Algorithms
GraphPad Prism 6 GraphPad Software, Inc., California
FlowJo 10.2 TreeStar, FlowJo LLC, Ashland, Oregon
Image J NIH, Bethesda, MarylandCONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Martin
Guilliams (martin.guilliams@irc.vib-ugent.be).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
In Vivo Animal Studies
The following mice were used in this study; Zeb2fl/fl (Higashi et al., 2002), Nr1h3fl/fl Itgax-cre (Caton et al., 2007), Rosa-RFP (Luche
et al., 2007), Rosa-26-creert2 (Ventura et al., 2007), Clec4f-cre (B6-Clec4f tm3Ciphe; were developed by the Centre d’Immunopheno-
mique, Marseille, France) and Fcgr1-cre (B6-Fcgr1tm3Ciphe; generated by Bernard Malissen). All mice were used on a C57Bl/6 back-
ground and a mix of male and female mice were used for each experiment. Mice were used between 6 and 8 weeks of age unless
otherwise stated. All micewere bred andmaintained at the VIB (Ghent University) under specific pathogen free conditions. All animals
were randomly allocated to experimental groups and littermate controls were used in all experiments. All experiments were
performed in accordance with the ethical committee of the Faculty of Science of the VIB.Immunity 49, 312–325.e1–e5, August 21, 2018 e2
Construction of Clec4f-IRES-iCRE Mice
Using ET recombination, an IRES-iCRE-loxP-Cre-NeoR-loxP cassette was introduced in the 3’ untranslated region of the Clec4f
gene, downstream of the stop codon. JM8.F6 C57BL/6N ES cells (Pettitt et al., 2009) were electroporated with the targeting vector.
After selection in G418, ES cell clones were screened for proper homologous recombination by Southern blot. A neomycin-specific
probe was used to ensure that adventitious non-homologous recombination events had not occurred in the selected ES clones.
Properly recombined ES cells were injected into FVB blastocysts. Germline transmission led to the self-excision of the loxP-Cre-
NeoR-loxP cassette in male germinal cells. The resulting Clec4f-IRES-iCRE allele (official name B6-Clec4fm2Ciphe, called here
Clec4f-cre) was identified by PCR of tail DNA. The primers: sense 5’-GATTCCCCTTCAGACCCTGAAT-3’, sense 5’-TGATGAACTA
CATCAGAACCTGG-3’ and antisense 5’-TATTGAGGGCTTATCTGGGC-3’ amplify a 496 bp band in case of the wild-type Clec4f
allele and a 304 bp band in the case of the Clec4f-IRES-iCre allele.
Construction of Fcgr1-IRES-iCRE-2A-TEAL Mice
Using ET recombination, an IRES-iCRE-2A-TEAL-frt-neoR-frt cassette was introduced in the 3’ untranslated region of the Fcgr1
gene, downstream of the stop codon. The targeting construct was abutted to a cassette coding for the diphtheria toxin
fragment A, and linearized with Pme1. JM8.F6 C57BL/6N ES cells (Pettitt et al., 2009) were electroporated with the targeting vector.
After selection in G418, ES cell clones were screened for proper homologous recombination by Southern blot. A neomycin-specific
probe was used to ensure that adventitious non-homologous recombination events had not occurred in the selected ES clones.
Properly recombined ES cells were injected into FVB blastocysts. Upon germline transmission, mice were then crossed to mice ex-
pressing the site-specific recombinase FLP (Kranz et al., 2010) to delete the frt-flanked neoR cassette. The resulting Fcgr1-IRES-
iCRE-TEAL floxed allele (official name B6-Fcgr1tm2Ciphe, called here Fcgr1-cre)was identified by PCR of tail DNA. The primers: sense
5’-CCCTTCCTCCCAGTGACAGTACTG-3’, sense 5’-GACGGCATGGACGAGCTGTACA-3’ and antisense 5’-TGAACCCATC
CACCCTGTGAG-3’ amplify a 402 bp band in case of the wild-type Fcgr1 allele and a 464 bp band in the case of the Fcgr1-IRES-
iCre-TEAL allele.
METHOD DETAILS
Isolation of Tissue Leukocytes
For the isolation of liver leukocytes, livers were isolated from PBS-perfused mice, chopped finely and subjected to GentleMACS
dissociation and incubated for 20 min with 1 mg/ml Collagenase A (Sigma) and 10U/ml DNase (Roche) in a shaking water bath at
37C. Following a second round of GentleMACS dissociation, single cell suspensions were filtered over a 100um filter. For the isola-
tion of lung, brain and spleen leukocytes, lungs, brains, kidneys and spleens were isolated from PBS-perfused mice finely chopped
and incubated for 30min with 0.2 mg/ml Liberase TM (Roche) and 10 U/ml DNase (Roche) in a shaking water bath at 37C. Single cell
suspensions frombrain were then subjected to a 100:40 percoll gradient (Sigma) to isolate leukocytes. Colonic intestinal lamina prop-
ria leukocytes were isolated as described previously (Bain et al., 2013; Scott et al., 2015).
Generation of BM Chimeras
Partially-protected: 6 week-oldClec4f-crexZeb2fl/fl, Itgax-creXZeb2fl/fl or Zeb2fl/fl littermate controls (CD45.2) were anaesthetized by
intraperitoneal administration of Ketamine (150mg/kg) and Xylazine (10mg/kg). Livers or lungswere protected with a 3-cm-thick lead
cover before mice were lethally irradiated with 8 Gy. Once recovered from the anesthesia, mice were reconstituted by intravenous
administration of 10x106 BMcells from congenic CD45.1 or CD45.1/CD45.2 BM fromwild-typemice. 4weeks after irradiation chime-
rism in the blood and liver or lung was assessed by flow cytometry.
Non-protected: 6-8 week old CD45.1 or CD45.1xCD45.2 WT mice were lethally irradiated with 8 Gy. Mice were reconstituted with
2-3X106 BM cells from gender-matched Zeb2fl/fl or Rosa-26-creert2xZeb2fl/fl (CD45.2) mice. At least 8 weeks post irradiation mice
were fed 5mg tamoxifen by oral gavage daily for 5 days before being sacrificed at the indicated time-points after the final dose.
Flow Cytometry
Cells (0.5–5 106) were stained with appropriate antibodies at 4C in the dark for 30-45 mins and were analyzed with a Fortessa (BD
Biosciences) and FlowJo software (TreeStar). KCs, AMs, splenic macs, colonic macs and microglia were sorted using an ARIA II or
ARIA III (BD, Biosciences). The full list of antibodies used can be found in the Key Resource Table. Primeflow assay (Thermo Fisher)
for Zeb2 expression was performed in 96-well U bottom plates according to the manufacturer’s instructions using commercially
available Zeb2 primers (Thermo Fisher).
Microarray
25000 AMs and Microglia from WT mice were sorted into 500ul RLT buffer (QIAGEN). RNA was isolated using the RNeasy micro kit
(QIAGEN) and sent to the Nucleomics facility, VIB Leuven, Belgium where the microarrays were performed using the GeneChip
MouseGene 1.0 ST arrays (Affymetrix). Sampleswere subsequently analyzed using R/Bioconductor. All samples passed quality con-
trol, and the Robust Multi-array Average (RMA) procedure was used to normalize data within arrays (probeset summarization, back-
ground correction and log2-transformation) and between arrays (quantile normalization). Only probesets that mapped uniquely to
one gene were kept, and for each gene, the probeset with the highest expression level was kept.e3 Immunity 49, 312–325.e1–e5, August 21, 2018
Bulk RNA Sequencing
25,000 KCs or AMs were FACS-purified into 500ml of RLT plus buffer (QIAGEN) and b-mercaptoethanol. RNA was isolated using a
RNeasy Plus micro kit (QIAGEN) and sent to the VIB Nucleomics facility, where the RNA sequencing was performed using a NextSeq
sequencer (Illumina). The pre-processing of the RNA sequencing data was done by Trimmomatic. The adapters were cut and reads
were trimmedwhen the quality dropped below 20. Readswith a length <35were discarded. All samples passed quality control based
on the results of FastQC. Reads were mapped to the mouse reference genome via Tophat2 and counted via HTSeqCount. Samples
were subsequently analyzed using R/Bioconductor, and the limma (voom) procedure was used to normalize the data.
Single Cell RNA Sequencing
Sorting and RNA Isolation
60000 Clec4F+CD64+F4/80+CD45+ Live cells from livers of Clec4-crexZeb2fl/fl and Zeb2fl/fl littermate controls, 60000 CD11c+-
SiglecF+F4/80+CD64+CD45+ Live cells from lungs of Itgax-crexZeb2fl/fl and Zeb2fl/fl littermate controls, 20000 CD45int,
F4/80+CD64+ live cells from brains of Fcgr1-crexZeb2fl/fl and Zeb2fl/fl littermate controls, 60000 CD45+Ly6C-Ly6G-SiglecF-
CD64+F4/80+ live cells from colons of Fcgr1-crexZeb2fl/fl and Zeb2fl/fl littermate controls and 60000 CD45+
Ly6C-Ly6G-SiglecF-CD64+F4/80+ live cells from spleens of Fcgr1-crexZeb2fl/fl and Zeb2fl/fl littermate controls were FACS-purified.
Cells were sorted into PBS 0.04% BSA, spun down and resuspended in PBS with 0.04%BSA at an estimated final concentration of
1000 cells/ml. Cellular suspensions (target recovery of 6000 cells) were loaded on a GemCode Single-Cell Instrument (10x Genomics,
Pleasanton, CA, USA) to generate single-cell Gel Bead-in-EMulsion (GEMs). Single-cell RNA-Seq libraries were prepared using
GemCode Single-Cell 3ʹGel Bead and Library Kit (10x Genomics) according to the manufacturer’s instructions. Briefly, GEM-RT
was performed in 96-deep well reaction module: 55C for 45min, 85C for 5 min; end at 4C. After RT, GEMs were broken down
and the cDNA was cleaned up with DynaBeads MyOne Silane Beads (Thermo Fisher Scientific, 37002D) and SPRIselect Reagent
Kit (SPRI; Beckman Coulter; B23318). cDNA was amplified with 96-Deep Well Reaction Module: 98C for 3 min; cycled 12 times :
98C for 15s, 67C for 20 s, and 72C for 1 min; 72C for 1 min; end at 4C. Amplified cDNA product was cleaned up with SPRIselect
Reagent Kit prior to enzymatic fragmentation. Indexed sequencing libraries were generated using the reagents in the GemCode Sin-
gle-Cell 3ʹ Library Kit with the following intermediates: (1) end repair; (2) A-tailing; (3) adapter ligation; (4) post-ligation SPRIselect
cleanup and (5) sample index PCR. Pre-fragmentation and post-sample index PCR samples were analysed using the Agilent
2100 Bioanalyzer.
RNA Sequencing Analysis
Sequencing libraries were loaded on an Illumina NextSeq500 (KCs, AMs) or HiSeq (Microglia, splenic macs, colonic macs) with
sequencing settings following recommendations of 10X Genomics (26/8/0/98 - 2.1pM loading concentration). Sequencing was per-
formed at the VIB Nucleomics Core (VIB, Leuven). The demultiplexing of the raw data was done by the 10x’s CellRanger software
(version 2.0.0 (KCs, AMs) or version 2.0.2 (Microglia, splenic macs, colonic macs); cellranger mkfastq which wraps Illumina’s
bcl2fastq). The reads obtained from the demultiplexing were used as the input for ‘cellranger count’ (10x’s CellRanger software)
which align the reads to the mouse reference genome (mm10) using STAR and collapses to unique molecular identifier (UMI) counts.
The result is a large digital expression matrix with cell barcodes as rows and gene identities as columns. The aggregation of the CRE-
and CRE+ samples was done using ‘cellranger aggr’ (10x’s CellRanger software). For heatmaps, each column corresponds to a sin-
gle cell.
Preprocessing Data
Preprocessing of the datawas done by the scran and scater R package according toworkflow proposed by theMarioni lab (Lun et al.,
2016). Outlier cells were identified based on 3 metrics (library size, number of expressed genes and mitochondrial proportion) and
cells were tagged as outliers when they were 3 median absolute deviation (MADs) away from the median value of each metric across
all cells. Low-abundance genes were removed using the ‘calcAverage’ function and the proposed workflow. The raw counts were
normalised and log2 transformed by first calculating ‘‘size factors’’ that represent the extent to which counts should be scaled in
each library. Detecting highly variable genes, finding clusters and creating tSNE plots was done using the Seurat pipeline. Marker
genes per identified subpopulation were found using the findMarker function of the Seurat pipeline. Additional low quality (low
UMI counts, high % of mitochondrial genes), contaminating (potential doublets) and actively proliferating cells were also removed
from the analysis (Figure S1G).
Gene-Expression Analysis by Real-Time RT-PCR
RNA was purified from 10000-25000 sorted cells using an RNeasy Plus micro kit (QIAGEN). RNA was reverse transcribed to cDNA
with an iScript Advanced cDNA Synthesis kit (Bio-Rad Laboratories). Gene expression was assayed by real-time RT-PCR using a
SensiFast SYBR NoRox kit (GC Biotech) on a PCR amplification and detection instrument (LightCycler 480; Roche) with the primers
listed in the Key Resource Table. Gene expression was normalized to b-actin, and the mean relative gene expression was calculated
using the 2DDC(t) method.
Confocal Microscopy
2-3mm slices of livers were fixed by immersion in Antigen fix (Diapath) for 1h, washed in PBS, infused overnight in 30% sucrose and
frozen in Tissue-Tek OCT compound (Sakura Finetek) for cryostat sectioning. After permeabilization with 0.5% saponin and unspe-
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cryostat tissue sections were labeled overnight at 4Cwith primary antibodies followed by incubation for 1 hour at room temperature
with secondary antibodies. When two rat antibodies were used on the same section, the directly conjugated rat antibody was incu-
bated for 1h after blocking with a donkey anti-rat secondary antibody with 1% rat serum for 30 minutes. Slices were mounted on
ProLong Diamond (Thermo Fisher Scientific) and imaged with a Zeiss LSM 780 confocal microscope (Carl Zeiss, Oberkochen, Ger-
many). Images were analyzed using ImageJ software.
PCR Analysis of Zeb2 Deletion
25000 cells of required phenotype and genotype were FACS-purified from livers and lungs of Clec4f-crexZeb2fl/fl and
Itgax-crexZeb2fl/fl mice respectively. DNA was extracted by boiling the cells at 95C in 50ml 50mM NaOH for 20minutes. After boiling
5ml 1.5M Tris pH8.8 was added to the cells. 1 or 0.2ml pf extracted DNA was added to a PCR reaction containing primer pairs
(Zeb2PCR) listed in the key resource table and Allin Red Taq polymerase (HighQu). PCRprotocol was as follows: 95C 1min, 40 cycles
of 95C 15secs, 62C 15secs, 72C 30secs and a 5min incubation at 72C. PCR products were resolved on a 2% agarose gel.
QUANTIFICATION AND STATISTICAL ANALYSIS
In all experiments, data are presented as mean ± SEM unless stated otherwise. Statistical tests were selected based on appropriate
assumptions with respect to data distribution and variance characteristics. Student’s t test (two-tailed) was used for the statistical
analysis of differences between two groups. One-way ANOVA with Bonferroni post-test was used for the statistical analysis of dif-
ferences between more than two groups. Statistical significance was defined as p < 0.05. Sample sizes were chosen according to
standard guidelines. Number of animals is indicated as ‘‘n.’’ Of note, sizes of the tested animal groups were also dictated by avail-
ability of the transgenic strains and litter sizes, allowing littermate controls. Pre-established exclusion criteria are based on IACUC
guidelines. The investigator was not blinded to the mouse group allocation.
DATA AND SOFTWARE AVAILABILITY
All RNA-sequencing data have been deposited in the Gene Expression Omnibus public database under accession number
GSE117081.e5 Immunity 49, 312–325.e1–e5, August 21, 2018
